Fatigue and brain atrophy in Egyptian patients with relapsing remitting multiple sclerosis. 2022

Eman M Khedr, and Tarek Desoky, and Ayman Gamea, and Mohammed Y Ezzeldin, and Ahmed F Zaki
Department of Neuropsychiatry, Faculty of Medicine, Assiut University Hospital, Assiut, Egypt; Neuropsychiatric Department, Faculty of Medicine, Aswan University Hospital, Aswan, Egypt. Electronic address: emankhedr99@yahoo.com.

BACKGROUND Fatigue is the most troublesome symptom in relapsing remitting multiple sclerosis (RRMS). It starts early in the disease course, escalates with disease progression and impacts the patients` quality of life. The aim of this work was to estimate the frequency of fatigue and to evaluate the relationship between severity of fatigue, clinical data, level of disability and volumetric brain atrophy in RRMS. METHODS 43 RRMS patients with 40 age- and sex-matched normal volunteers were recruited. Demographic and clinical data were recorded. Each participant was assessed with the Expanded Disability Status Scale (EDSS), Fatigue Severity Scale (FSS), Brief Cognitive Assessment for Multiple Sclerosis (BICAMS) and a variety of brain volumetric measures. RESULTS 31 (72.1%) of RRMS patients were found to have fatigue. There were no significant differences in demographic data between patients with or without fatigue according to FSS. However, patients with fatigue had a higher number of attacks, and higher scores in the EDSS and BICAMS than non-fatigued patients. There was a greater reduction in total brain volume, cerebral grey matter, and brain stem, thalamic and caudate volumes in fatigued compared with the non-fatigued patients and controls. FSS was significantly correlated with patients' age, duration of illness, total number of attacks, EDSS, and BICAMS. Total brain, cerebral grey matter and thalamic volumes all had negative correlations with fatigue severity. Regression analysis showed that EDSS accounted for 46% of the variance in fatigue scores while thalamic and brainstem atrophy accounted for 50.7%. CONCLUSIONS Fatigue was fairly common in RRMS patients. Level of disability and atrophy of the thalamus and brain stem were the best predictors of fatigue.

UI MeSH Term Description Entries
D008297 Male Males
D001921 Brain The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM. Encephalon
D004534 Egypt A country in northern Africa, bordering the Mediterranean Sea, between Libya and the Gaza Strip, and the Red Sea north of Sudan, and includes the Asian Sinai Peninsula Its capital is Cairo. Arab Republic of Egypt,United Arab Republic
D005221 Fatigue The state of weariness following a period of exertion, mental or physical, characterized by a decreased capacity for work and reduced efficiency to respond to stimuli. Lassitude
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001284 Atrophy Decrease in the size of a cell, tissue, organ, or multiple organs, associated with a variety of pathological conditions such as abnormal cellular changes, ischemia, malnutrition, or hormonal changes. Atrophies
D012720 Severity of Illness Index Levels within a diagnostic group which are established by various measurement criteria applied to the seriousness of a patient's disorder. Illness Index Severities,Illness Index Severity
D016022 Case-Control Studies Comparisons that start with the identification of persons with the disease or outcome of interest and a control (comparison, referent) group without the disease or outcome of interest. The relationship of an attribute is examined by comparing both groups with regard to the frequency or levels of outcome over time. Case-Base Studies,Case-Comparison Studies,Case-Referent Studies,Matched Case-Control Studies,Nested Case-Control Studies,Case Control Studies,Case-Compeer Studies,Case-Referrent Studies,Case Base Studies,Case Comparison Studies,Case Control Study,Case Referent Studies,Case Referrent Studies,Case-Comparison Study,Case-Control Studies, Matched,Case-Control Studies, Nested,Case-Control Study,Case-Control Study, Matched,Case-Control Study, Nested,Case-Referent Study,Case-Referrent Study,Matched Case Control Studies,Matched Case-Control Study,Nested Case Control Studies,Nested Case-Control Study,Studies, Case Control,Studies, Case-Base,Studies, Case-Comparison,Studies, Case-Compeer,Studies, Case-Control,Studies, Case-Referent,Studies, Case-Referrent,Studies, Matched Case-Control,Studies, Nested Case-Control,Study, Case Control,Study, Case-Comparison,Study, Case-Control,Study, Case-Referent,Study, Case-Referrent,Study, Matched Case-Control,Study, Nested Case-Control
D018450 Disease Progression The worsening and general progression of a disease over time. This concept is most often used for chronic and incurable diseases where the stage of the disease is an important determinant of therapy and prognosis. Clinical Course,Clinical Progression,Disease Exacerbation,Exacerbation, Disease,Progression, Clinical,Progression, Disease

Related Publications

Eman M Khedr, and Tarek Desoky, and Ayman Gamea, and Mohammed Y Ezzeldin, and Ahmed F Zaki
February 2002, Brain : a journal of neurology,
Eman M Khedr, and Tarek Desoky, and Ayman Gamea, and Mohammed Y Ezzeldin, and Ahmed F Zaki
August 2004, Journal of the neurological sciences,
Eman M Khedr, and Tarek Desoky, and Ayman Gamea, and Mohammed Y Ezzeldin, and Ahmed F Zaki
June 2000, Arquivos de neuro-psiquiatria,
Eman M Khedr, and Tarek Desoky, and Ayman Gamea, and Mohammed Y Ezzeldin, and Ahmed F Zaki
December 2015, Journal of neurology,
Eman M Khedr, and Tarek Desoky, and Ayman Gamea, and Mohammed Y Ezzeldin, and Ahmed F Zaki
January 2016, Neurodegenerative disease management,
Eman M Khedr, and Tarek Desoky, and Ayman Gamea, and Mohammed Y Ezzeldin, and Ahmed F Zaki
April 2005, Journal of the neurological sciences,
Eman M Khedr, and Tarek Desoky, and Ayman Gamea, and Mohammed Y Ezzeldin, and Ahmed F Zaki
January 2023, PloS one,
Eman M Khedr, and Tarek Desoky, and Ayman Gamea, and Mohammed Y Ezzeldin, and Ahmed F Zaki
March 2000, Radiology,
Eman M Khedr, and Tarek Desoky, and Ayman Gamea, and Mohammed Y Ezzeldin, and Ahmed F Zaki
December 2016, Multiple sclerosis (Houndmills, Basingstoke, England),
Eman M Khedr, and Tarek Desoky, and Ayman Gamea, and Mohammed Y Ezzeldin, and Ahmed F Zaki
October 2010, Multiple sclerosis (Houndmills, Basingstoke, England),
Copied contents to your clipboard!